Antipsychotics TDM Market Size Analysis 2023

1
Antipsychotics TDM Market (2023-29)
2
Market Overview
The global antipsychotics tdm market size was
valued at USD 222,1 million in 2022 and is poised
to grow at a significant CAGR of 5.8 during the
forecast period 2023-29. The antipsychotics tdm
market research report also provides
opportunities for business owners to exploit
through the use of relevant approaches. The
studys prospects assist stakeholders and report
purchasers in properly planning their investments
and augmenting their profits. The report
provides a quantitative analysis of the market
segments, trends, estimations, and dynamics of
the antipsychotics tdm market analysis from 2023
to 2029 to identify the prevailing market
opportunities. In addition, the report discusses
the implications of COVID-19, including the
industry's initial response and strategies for
ensuring business continuity in the coming
years. View Detailed Report Description
3
Market Segments
The antipsychotics tdm market has been fragmented
based on1) By Drug Type Aripiprazole,
Clozapine, Haloperidol, Olanzapine, Ziprasidone,
Chlorpromazine, Lithium, Lurasidone,
Paliperidone, Perphenazine, Quetiapine,
Risperidone, Thiothixene 2) By Technology
Immunoassay, LC-MS/MS, GC-MS/MS Request Sample
Report
4
Key Players
Some of the major key players in the
antipsychotics tdm market are Roche
Diagnostics Sekisui Diagnostics Thermo Fischer
Scientific Beckman Coulter ChromSystems Abbott
Diagnostics Siemens Healthineers. Request Sample
Report
5
Europe Office Precision Business Insights, Kemp
House, 152 160 City Road, London EC1V
2NX Asia-Pacific Office Precision Business
Insights, MIG 366, SAI PLAZA, 1st Floor, KPHB
Colony, Hyderabad 500072 Email sales_at_precisionb
usinessinsights.com Toll-Free 1-866-598-1553